Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery
Autor: | Stacia M. DeSantis, A Lauren Haney, Francis G. Spinale, Andrew M. Atz, Rachael L. Deardorff, Eric M. Graham, Scott M. Bradley, Scott Reeves, Walter E. Uber, Jenna F Gillis, Francis X. McGowan |
---|---|
Rok vydání: | 2012 |
Předmět: |
Heart Defects
Congenital Male Pulmonary and Respiratory Medicine Time Factors South Carolina Blood Loss Surgical Factor VIIa Platelet Transfusion Postoperative Hemorrhage Risk Assessment Article Aprotinin Risk Factors Blood product Antifibrinolytic agent medicine Humans Cardiac Surgical Procedures Retrospective Studies Analysis of Variance Chi-Square Distribution Tumor Necrosis Factor-alpha business.industry Age Factors Infant Newborn Acute kidney injury Perioperative medicine.disease Hospital Charges Respiration Artificial Antifibrinolytic Agents Recombinant Proteins Treatment Outcome Platelet transfusion Tranexamic Acid Anesthesia Cryoprecipitate Cytokines Interleukin-2 Female Surgery Inflammation Mediators Erythrocyte Transfusion Cardiology and Cardiovascular Medicine business Tranexamic acid medicine.drug |
Zdroj: | The Journal of Thoracic and Cardiovascular Surgery. 143:1069-1076 |
ISSN: | 0022-5223 |
DOI: | 10.1016/j.jtcvs.2011.08.051 |
Popis: | ObjectiveFactors contributing to postoperative complications include blood loss and a heightened inflammatory response. The objective of this study was to test the hypothesis that aprotinin would decrease perioperative blood product use, reduce biomarkers of inflammation, and result in improved clinical outcome parameters in neonates undergoing cardiac operations.MethodsThis was a secondary retrospective analysis of a clinical trial whereby neonates undergoing cardiac surgery received either aprotinin (n = 34; before May 2008) or tranexamic acid (n = 42; after May 2008). Perioperative blood product use, clinical course, and measurements of cytokines were compared.ResultsUse of perioperative red blood cells, cryoprecipitate, and platelets was reduced in neonates receiving aprotinin compared with tranexamic acid (P |
Databáze: | OpenAIRE |
Externí odkaz: |